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Abstract
OBJECTIVE: To study the effects of Zhiweifangbian
(ZWFB) capsule on lactic dehydrogenase (LDH), suc-
cinic dehydrogenase (SDH) and ATPase activities
in gastric mucosa of chronic atrophic gastritis
(CAG) rats with Qi deficiency and blood stasis syn-
drome.
METHODS: Totally 90 rats were randomly divided
into 2 groups: normal group (n=10) and model
group (n=80). The CAG rat model of Qi deficiency
and blood stasis type was induced by synthetic
methods. After modeling for 12 weeks and the suc-
cessful CAG model was determined, the CAG mod-
el rats were divided by random number table into
model group (MG), ZWFB high-dose group
(ZWFBH), ZWFB middle-dose group (ZWFBM),
ZWFB low-dose group (ZWFBL) and Weimeisu
group (WM), 9 rats in each group. The rats in the
normal and model groups were intragastrically ad-
ministrated with distilled water, 10 mL/kg every
day; the ZWFB high-dose group with ZWFB, 0.6 g/
kg-1·d-1; the ZWFB middle-dose group with ZWFB,
0.3 g/kg-1·d-1; the ZWFB low-dose group with
ZWFB, 0.15 g/kg-1·d-1 , and the WM group with sus-
pension of WM , 0.25 g/kg-1·d-1 . The treatment was
given for 90 consecutive days. Then general surviv-
al states were observed and the activities of LDH,
SDH, Na+-K+-ATPase and Ca2+-Mg2+-ATPase in gastric
mucosa tissue were detected.
RESULTS: Compared with the normal group, activi-
ty of LDH in the gastric mucosa (P<0.05) and activi-
ties of SDH, Na+-K+-ATPase and Ca2+-Mg2+-ATPase sig-
nificantly decreased in the normal group (P<0.05).
Compared with the model group the activity of
LDH decreased and activities of SDH, Na+-K+-ATPase
and Ca2+-Mg2+-ATPase significantly increased in the
high dose ZWFB group (P<0.05).
CONCLUSION: ZWFB capsule can promote energy
metabolism and ATPase activity in the gastric mu-
cosa cell, so as to protect the function of the gastric
mucosa cell.
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INTRODUCTION
Chronic atrophic gastritis (CAG) is a common disease
in the digestive system. When accompanied with atypi-
cal hyperplasia and intestinal metaplasia, it is consid-
ered as precancerous lesion, with an incidence of gas-
tric cancer up to 10%.1 Traditional Chinese Medicine
(TCM) holds that for main pathogenesis of CAG,
spleen-stomach Qi deficiency is primary and the syn-
drome of Qi-stagnation and blood stasis is secondary.
A large number of clinical cases have confirmed that
TCM has an obvious advantage in prevention and
treatment of the disease.2 Zhiweifangbian (ZWFB) cap-
sule is an effective hospital preparation developed on
the basis of the clinical effective prescription (modified
Xiangshaliujunzi decoction), indicated for CAG of Qi
deficiency and blood stasis type. The previous studies
indicated that ZWFB capsule could protect and repair
the gastric mucosa cell by elevating antioxidation en-
zyme activity and lessening free radical injury, amelio-
rating blood flow and microcirculation of the gastric
mucosa, promoting secretion of somatostatin and gas-
tric acid.3-5 This study aims to observe effects of ZWFB
capsule on lactic dehydrogenase (LDH), succinic dehy-
drogenase (SDH) and ATPase activities in the gastric
mucosa, and to further explore the mechanisms in pre-
venting and treating CAG.
MATERIALS ANDMETHODS
Animals
Ninety healthy Wistar rats of SPF grade (45 males and
45 females), three-month-old, weighing (180 ± 20) g,
were supplied by the Medical Research Center of Gan-
su College of TCM (Certificate of quality No: SCXK
[gan] 2004-0006-0000202) and fed in the Laboratory
Animal Center of Gansu College of Traditional Chi-
nese Medicine. The study was approved by the experi-
mental animal ethics committee of Gansu University
of TCM.
Drugs
ZWFB capsule was composed of 12 Chinese medical
herbs, including Renshen (Radix Ginseng), Baizhu (Rhi-
zoma Atractylodis Macrocephalae), Fulin (Poria), Zhishi
(Fructus Aurantii Immaturus), Sharen (Fructus Amomi),
Muxiang (Radix Aucklandiae), Chenpi (Pericarpium
Citri Reticulatae), Banxia (Rhizoma Pinelliae), Bai-
huasheshecao (Herba Hedyotidis), Sanqi (Radix Notogin-
seng), etc. batch No. 100106 (prepared by the Prepara-
tion Room, Gansu College of Traditional Chinese
Medicine Affiliated Hospital, Lanzhou, Gansu, China,
0.4 g/tablet). Wei Meisu, batch No. 060407 (Shan-
dong Lubei Pharmaceutical Co., Ltd., Shandong, Chi-
na, 0.2 g/tablet).
Main reagents and instruments
Coomassie blue protein assay kit, lot No. 20110719,
LDH kit, lot No. 20110714, SDH kit, lot No.
20110716, Na+-K+-ATPase kit, lot No. 20110720 and
Ca2 +-Mg2 +-ATPase kit, lot No. 20110719 (Nanjing Ji-
ancheng Bioengineering Institute, Nanjing, China);
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), lot
No. 68051 (Fluka Company, Switzerland); Ranitidine
hydrochloride capsules, lot No. 110125 (Jiangxi Hui-
ren Pharmaceutical Ltd, Nanchang, China).
DF110 electronic analytical balance (Changshu Weigh-
ing Apparatus Industrial Company, Changzhou, Chi-
na); 7221 visible spectrophotometer (Shanghai Jinghua
Science and Technology Instrument Co., Ltd., Shang-
hai, China); XYJ80-2 centrifuge (Tangxia Junyue Me-
chanical and Electrical Equipment Factory of Dong-
guan City, China); HH-4 digital thermostat water bath
box (Jintan City Youlian Instrument Research Insti-
tute, China).
Modeling and grouping
Totally 90 rats were randomly divided into 2 groups by
random number table method: normal group (n=10)
and modeling group (n=80). The normal group (NG)
was fed with normal diet. The 80 rats were used to es-
tablish CAG model of Qi deficiency and blood stasis
type based on Lu weiming's method:6 (a) The rats were
free access to 0.1 mg/mL N-Methyl-N'-nitro-N-ni-
trosoguanidine (MNNG) prepared with sterilized wa-
ter (The MNNG solution was protected from light
and prepared once each day). (b) The rats were fed by
the irregular feeding method, full feeding for 2 days
and fasting for one day. (c) The rats were intragastrical-
ly administrated with ranitidine hydrochloride capsule,
0.03 g/kg once a day. After 60 days of modeling, a rat
was decapitated after anesthesia every other week and
the gastric mucosa was taken out for biopsy to detect
intestinal metaplasia till the 12th week. After the for-
mation of intestinal metaplasia the treatment started to
be given. According to the weight of the CAG rat, they
were numbered and grouped by random number table
method into the model group (MG), ZWFB high-dose
group (ZWFBH), ZWFB middle-dose group
(ZWFBM), ZWFB low-dose group (ZWFBL), Wei-
meisu group (WM), 9 rats in each group. Males and fe-
males were caged separately.
Administration
The rats in NG and MG were intragastrically adminis-
trated with distilled water, 10 mL/kg each day. The rats
in ZWFBH, ZWFBM and ZWFBL were respectively
intragastrically administrated with ZWFB 0.6 g/kg-1·
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d-1, 0.3 g/kg-1·d-1 and 0.15 g/kg-1·d-1 (equivalent to 10
times, 5 times and 2 times of 60 kg adult dose per
day). The rats in WM were intragastrically administrat-
ed with 0.25 g/kg-1·d-1 vatacoenayme (equivalent to 5
times of 60 kg adult dose per day). The equivalent dose
was come from people and animal body coefficient
conversion.7 The treatment was given for 90 days.
Specimen collection
All animals in the groups were fasted for 24 h with
free access to water after the last treatment and then
were weighted, and killed after anesthesia by ure-
thane (1 g/kg).
Preparation of gastric mucosal tissue homogenate
After blood collection, animals were killed. Gastric mu-
cosa tissue was taken out quickly at low temperature
(－1℃), washed with cold saline, sucked with filter pa-
per, weighed and cut into pieces with a small scissors as
soon as possible, and homogenized with saline of 9
times of tissue weight (the end of homogenizer was
placed in the icy water), centrifuged at 3500 r·min-1
for 10 min and the supernatant was stored at 4℃ refrig-
erator for measuring LDH, SDH, Na+-K+-ATPase and
Ca2+-Mg2+-ATPase activities by chemical colorimetry.
Statistical analysis
All the data were processed by SPSS13.0 statistical soft-
ware (Statistical Product and Service SolutionsInc.,
Chicago, IL, USA) and expressed as means ± standard
deviation, and one-way ANOVA was used for compari-
son among groups and LSD test was used for compari-
son between groups, P<0.05 was regarded as significant
difference.
RESULTS
General state of rats in the groups
The rats in NG acted flexibly, with lustrous and clean
hair, normal and stable food intake, granular stool and
pink tail. After five weeks, the rats in MG appeared lan-
guid and lack of activity, slower increase of body
weight (emaciation), lost appetite, a sprawl of hair, and
dry or lose stool. After intervention for 7 weeks, the
rats in ZWFB and WM groups had some increase of
body weight, good food intake and activity, lustrous
hair and granular stool.
Effects of Zhiweifangbian capsule on gastric mucosa
LDH and SDH activities in rats
Compared with NG, LDH activity increased and
SDH significantly decreased in MG (P<0.05). Com-
pared with MG, the LDH activity significantly de-
creased and SDH increased in the high dose ZWFB
group and WM group (P<0.05), which were shown in
Table 1.
Effects of Zhiweifangbian capsule on gastric mucosa
Na+-K+-ATPase and Ca2+-Mg2+-ATPase activities in
rats
Compared with NG, activities of gastric mucosa
Na+-K+-ATPase and Ca2+-Mg2+-ATPase significantly de-
creased in MG (P<0.05). Compared with MG, activi-
ties of gastric mucosa Na +-K +-ATPase and
Ca2 +-Mg2 +-ATPase significantly increased in the high
dose ZWFB group and WM group (P<0.05), which
were shown in Table 2.
DISCUSSION
Chronic atrophic gastritis is a commonly-seen disease
Group
NG
MG
ZWFBH
ZWFBM
ZWFBL
WM
n
10
9
9
9
9
9
Dose
(g/kg)
-
-
0.60
0.30
0.15
0.25
LDH
(U/mg prot)
6.1±1.3
9.6±2.4a
7.5±2.1b
8.6±2.5
9.0±2.6
7.3±2.4b
SDH
(U/mg prot)
15.4±2.7
11.8±2.5a
14.8±2.7b
12.4±2.1
13.0±3.6
14.4±2.7b
Notes: NG: Normal group; MG: Model group; ZWFB: Zhi-
weifangbian; ZWFBH: High dose ZWFB; ZWFBM: Middle
dose ZWFB; ZWFBL: Low dose ZWFB; WM: Weimeisu.Com-
pared with the normal group, aP<0.05; Compared with the mod-
el group, bP<0.05.
Table 1 Comparison of gastric mucosa LDH and SDH activi-
ties among the groups ( xˉ ±s)
Group
NG
MG
ZWFBH
ZWFBM
ZWFBL
WM
n
10
9
9
9
9
9
Dose
(g/kg)
-
-
0.60
0.30
0.15
0.25
Na+-K+-ATPase
(U/mg prot)
6.6±0.8
5.1±1.1a
6.2±1.3b
5.7±1.1
5.5±1.1
6.2±1.1b
Ca2+-Mg2+-ATPase
(U/mg prot)
7.7±1.5
6.2±1.0a
7.5±1.4b
6.9±1.4
6.5±1.5
7.2±1.4
Notes: NG: Normal group; MG: Model group; ZWFB: Zhiweifangbian; ZWFBH: High dose ZWFB; ZWFBM: Middle dose ZWFB;
ZWFBL: Low dose ZWFB; WM: Weimeisu. Compared with the normal group, aP<0.05; Compared with the model group, bP<0.05.
Table 2 Comparison of gastric mucosa Na+-K+-ATPase and Ca2+-Mg2+-ATPase activities among the groups ( xˉ ±s)
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of the digestive system, characterized by gastric mucosa
thinning, epithelial cell degeneration, inflammatory re-
sponse of inherent membrane, and atrophy of inherent
glands. Particularly, when companied with atypical hy-
perplasia and intestinal metaplasia, it is regarded as gas-
tric precancerous lesion. From the point of TCM, the
etiology of this disease is complex, but the basic patho-
genesis is mostly due to spleen and stomach Qi defi-
ciency, making dysfunction of middle-jiao, clear Yang
in spleen unable to ascend and turbid Yin in stomach
unable to descend. Thus it is induced by attack of
pathogenic factor. Prolonged illness causes disorder of
blood circulation and lack of nutrition in gastric muco-
sa, leading to lesions of gastric collaterals, such as atro-
phy of gastric mucosa inherent gland, intestinal meta-
plasia, inflammatory reaction, etc. Clinically, this dis-
ease has such symptoms as spleen-stomach deficiency,
anorexia, marasmus, anaemia, lassitude and weakness
(gastrointestinal motility disorders, weakened digestion
and absorption, low energy metabolism).
To analyze from the angle of cellular energy metabo-
lism, SDH activity reflects the active degree of tricar-
boxylic acid cycle and the level of cellular aerobic glu-
cose metabolism. Decrease of SDH activity shows that
aerobic oxidation reaction is weakened, energy supply
to cells is not enough and secretion function of cells is
reduced. Activity of LDH reflects the level of cellular
anaerobic glycolysis. In the present study, the increase
of LDH activity in MG possibly is due to the decrease
of SDH activity and aerobic oxidation of glucose,
while the anaerobic glycolysis provides energy for com-
pensation, which can further cause decreases of carbon-
ic anhydrase activity of parietal cells, release of hydro-
gen ions and synthesis of hydrochloric acid, leading to
achlorhydria, the reduction of pepsin activity and the
decrease of gastrointestinal digestion and secretion
function. Therefore, it can be inferred that abnormal
enzyme activity of membrane and decreased metabolic
function of cell possibly are one reason of gastric muco-
sa atrophy and digestive and absorptive dysfunctions.8
In recent years, studies have found that intracellular
Ca2 + overload is closely related to cell dysfunction.9
Moreover, Na +-K +-ATPase and Ca2 +-Mg2 +-ATPase are
the basis of Ca2+ normal distribution. Na+-K+-ATPase is
a glycoprotein located on the cell membrane, closely re-
lated with ATP decomposition and transportation of
intracellular and extracellular sodium and potassium
ions, and it also can block unfavorable factors influenc-
ing the membrane pump function. Therefore, it plays a
very important role in maintaining intracellular and ex-
tracellular osmotic pressure balance, transmembrane
electrochemical gradient and cell energy metabolism.
Ca2+-Mg2+-ATPase is also a membrane-binding enzyme
widely existing on cell membrane, and it can hydrolyze
ATP, transport the intracellular Ca2 + to outside of the
cell to maintain relatively low intracellular Ca2+ concen-
tration, which is an important mechanism for main-
taining homeostasis, and is the basis for cells to func-
tion properly. Studies have shown that free radical dam-
age inhibits the cell membrane Ca2+-Mg2+-ATPase activ-
ity, and free radicals can directly oxidize amino acid res-
idues of ATPase proteins to inactivate the enzyme and
finally cause imbalance of intracellular Ca2+ steady state
and dysfunction of cells.9
ZWFB capsule targets the pathogenesis of CAG with
Qi deficiency and blood stasis, with strengthening the
spleen and replenishing Qi, regulating Qi and activat-
ing blood circulation as treatment principle, which is
made by Renshen (Radix Ginseng), Baizhu (Rhizoma
Atractylodis Macrocephalae), Fulin (Poria), Zhishi (Fruc-
tus Aurantii Immaturus), Sharen (Fructus Amomi), Mux-
iang (Radix Aucklandiae), Chenpi (Pericarpium Citri
Reticulatae), Banxia (Rhizoma Pinelliae), Baihuasheshe-
cao (Herba Hedyotidis), Sanqi (Radix Notoginseng) and
other herbal medicines after extraction and separation ,
indicated for CAG of Qi deficiency and blood stasis
type. Modern pharmacological researches have proved
that active ingredients of ginseng,10 citrus aurantium,11
atractylodes,12 pinellia,13 hedyotis diffusa wild14 and
panax notoginseng15 can improve gastrointestinal
smooth muscle function, relieve spasm and relieve
pain, inhibit platelet aggregation and kill Helicobacter
pylori, as well as induce tumor cells apoptosis. Our re-
search results indicate that compared with NG, in MG
gastric mucosa LDH activity significantly increased (P<
0.05); SDH, Na+-K+-ATPase and Ca2+-Mg2+-ATPase ac-
tivities significantly reduced (P<0.05); Compared with
MG, in ZWFBH group gastric mucosa LDH activity
significantly decreased (P<0.05); SDH, Na+-K+-ATPase
and Ca2 +-Mg2 +-ATPase activities significantly increased
(P<0.05). It is suggested that a certain dose of ZWFBC
can promote the aerobic glucose metabolism of gastric
mucosa cells and the activity of cell membrane ATPase,
thereby protect functions of gastric mucosa cells.
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